These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30121214)

  • 1. Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.
    Patanapongpibul M; Zhang C; Chen G; Guo S; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem; 2018 Sep; 26(16):4751-4760. PubMed ID: 30121214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
    Wang R; Chen C; Zhang X; Zhang C; Zhong Q; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    J Med Chem; 2015 Jun; 58(11):4713-26. PubMed ID: 25961334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new class of hybrid anticancer agents inspired by the synergistic effects of curcumin and genistein: Design, synthesis, and anti-proliferative evaluation.
    Chen QH; Yu K; Zhang X; Chen G; Hoover A; Leon F; Wang R; Subrahmanyam N; Addo Mekuria E; Harinantenaina Rakotondraibe L
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4553-6. PubMed ID: 26341135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
    Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.
    Zhang X; Guo S; Chen C; Perez GR; Zhang C; Patanapongpibul M; Subrahmanyam N; Wang R; Keith J; Chen G; Dong Y; Zhang Q; Zhong Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2017 Sep; 137():263-279. PubMed ID: 28601720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of curcumin inspired imidazo[1,2-a]pyridine analogues as tubulin polymerization inhibitors.
    Ramya PVS; Guntuku L; Angapelly S; Digwal CS; Lakshmi UJ; Sigalapalli DK; Babu BN; Naidu VGM; Kamal A
    Eur J Med Chem; 2018 Jan; 143():216-231. PubMed ID: 29174816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
    Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
    Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel monocarbonyl analogue of curcumin, (1E,4E)-1,5-bis(2,3-dimethoxyphenyl)penta-1,4-dien-3-one, induced cancer cell H460 apoptosis via activation of endoplasmic reticulum stress signaling pathway.
    Wang Y; Xiao J; Zhou H; Yang S; Wu X; Jiang C; Zhao Y; Liang D; Li X; Liang G
    J Med Chem; 2011 Jun; 54(11):3768-78. PubMed ID: 21504179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of C5-curcuminoids and synthesis of their molecular probes thereof.
    Yamakoshi H; Ohori H; Kudo C; Sato A; Kanoh N; Ishioka C; Shibata H; Iwabuchi Y
    Bioorg Med Chem; 2010 Feb; 18(3):1083-92. PubMed ID: 20060305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models.
    Wang R; Zhang X; Chen C; Chen G; Sarabia C; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2017 Jun; 133():208-226. PubMed ID: 28388523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis and Evaluation of Novel Derivatives of Curcuminoids with Cytotoxicity.
    Chen CY; Lien JC; Chen CY; Hung CC; Lin HC
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
    Li X; Zhang C; Guo S; Rajaram P; Lee M; Chen G; Fong R; Gonzalez A; Zhang Q; Zheng S; Wang G; Chen QH
    Eur J Med Chem; 2018 Sep; 157():978-993. PubMed ID: 30165345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugates of 18β-glycyrrhetinic acid derivatives with 3-(1H-benzo[d]imidazol-2-yl)propanoic acid as Pin1 inhibitors displaying anti-prostate cancer ability.
    Li K; Ma T; Cai J; Huang M; Guo H; Zhou D; Luan S; Yang J; Liu D; Jing Y; Zhao L
    Bioorg Med Chem; 2017 Oct; 25(20):5441-5451. PubMed ID: 28838831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 1,5-bis(4-hydroxy-3-methoxyphenyl)penta-1,4-dien-3-one and its aminomethyl derivatives.
    Yerdelen KO; Gul HI; Sakagami H; Umemura N
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):383-8. PubMed ID: 25068729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
    Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
    Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bioactivity evaluation of penta-1,4-diene-3-one oxime ether derivatives.
    Tang X; Su S; Li Q; He J; Chen M; Chen Y; Wu J; Jiang S; Xue W
    J Pestic Sci; 2019 Nov; 44(4):242-248. PubMed ID: 32874125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer.
    Njar VC; Kato K; Nnane IP; Grigoryev DN; Long BJ; Brodie AM
    J Med Chem; 1998 Mar; 41(6):902-12. PubMed ID: 9526564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 4-(2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-7-yl)-N-(5-(piperazin-1-ylmethyl)pyridine-2-yl)pyrimidin-2-amine as a highly potent and selective cyclin-dependent kinases 4 and 6 inhibitors and the discovery of structure-activity relationships.
    Wang Y; Liu WJ; Yin L; Li H; Chen ZH; Zhu DX; Song XQ; Cheng ZZ; Song P; Wang Z; Li ZG
    Bioorg Med Chem Lett; 2018 Mar; 28(5):974-978. PubMed ID: 29429832
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.